Monkeypox Virus (Recombinant) Stock (1 x 1mL)
This product is intended to aid laboratories in the evaluation of nucleic acid tests designed to detect certain portions of the Monkeypox virus genome. Recombinant Monkeypox stock provides laboratories with a targeted, reliable control for PCR testing. It is the only ready-to-use, whole organism full-process molecular control for Monkeypox.
Recombinant Monkeypox stock is formulated with purified, intact bacterial cells containing synthetic Monkeypox virus sequence, to a target concentration of 1,000,000 cp/mL. The sequence includes portions of the E9L, G2R, B2R, and C3L gene regions, and the cells have been chemically modified to render them non-infectious and refrigerator stable.
• Organisms are chemically modified to render them noninfectious
• Refrigerator stable—store between 2 and 8°C
• 1.0 mL vial
For Research Use Only. Not for use in Diagnostic Procedures.
For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.
When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.
The suitability and performance characteristics should be determined by your laboratory for each intended usage.
NATtrol™ Monkeypox Virus (Recombinant) Stock is designed to evaluate the performance of nucleic acidtests for determination of the presence of Monkeypoxvirus DNA. NATtrol™ Monkeypox Virus (Recombinant)Stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and canprovide assistance in identifying random or systemicerror